ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Intangible Assets

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares posts a intangible assets of $0 as of December 2025. That compares with $34M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares's intangible assets was $34M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BIB's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares's other metric pages and overview cover the third.